BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30672409)

  • 21. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision gas therapy using intelligent nanomedicine.
    He Q
    Biomater Sci; 2017 Oct; 5(11):2226-2230. PubMed ID: 28937694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritising breast cancer theranostics: A current medical longing in oncology.
    Pandey PN; Saini N; Sapre N; Kulkarni DA; Tiwari DAK
    Cancer Treat Res Commun; 2021; 29():100465. PubMed ID: 34598060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision targeted therapy of ovarian cancer.
    Sapiezynski J; Taratula O; Rodriguez-Rodriguez L; Minko T
    J Control Release; 2016 Dec; 243():250-268. PubMed ID: 27746277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enabling individualized therapy through nanotechnology.
    Sakamoto JH; van de Ven AL; Godin B; Blanco E; Serda RE; Grattoni A; Ziemys A; Bouamrani A; Hu T; Ranganathan SI; De Rosa E; Martinez JO; Smid CA; Buchanan RM; Lee SY; Srinivasan S; Landry M; Meyn A; Tasciotti E; Liu X; Decuzzi P; Ferrari M
    Pharmacol Res; 2010 Aug; 62(2):57-89. PubMed ID: 20045055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 29. Future opportunities in cancer nanotechnology--NCI strategic workshop report.
    Grodzinski P; Farrell D
    Cancer Res; 2014 Mar; 74(5):1307-10. PubMed ID: 24413533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The photonic nanomedicine revolution: let the human side of nanotechnology emerge.
    Halas NJ
    Nanomedicine (Lond); 2009 Jun; 4(4):369-71. PubMed ID: 19505237
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
    Alexiou C; Tietze R; Schreiber E; Lyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer, signal transduction and nanotechnology.
    Sengupta P; Basu S; Sengupta S
    Curr Drug Deliv; 2011 May; 8(3):254-60. PubMed ID: 21291374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy.
    Chaturvedi VK; Singh A; Singh VK; Singh MP
    Curr Drug Metab; 2019; 20(6):416-429. PubMed ID: 30227814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanotechnology: nanomedicine.
    Kenwright K; Pifer LL
    Clin Lab Sci; 2010; 23(2):112-6. PubMed ID: 20499536
    [No Abstract]   [Full Text] [Related]  

  • 35. Nanotechnology for the diagnosis and treatment of diseases.
    Azzawi M; Seifalian A; Ahmed W
    Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317
    [No Abstract]   [Full Text] [Related]  

  • 36. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.
    Vizirianakis IS
    Nanomedicine; 2011 Feb; 7(1):11-7. PubMed ID: 21094279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedical engineering: shaping future nanomedicines.
    Luo D; Carter KA; Lovell JF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.